Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Unleashing the Power Within: Enhancing Cancer Treatment with Cytotoxic Invariant Natural Killer T Cells
FY 2023-24
Summary
Cancer is a disease that arises when cells divide uncontrollably. Typically, our cells adhere to a pattern of growth, division, and death. However, in cancer, errors occur, leading to persistent cell division and tumour formation. Typically, our immune system can recognize these errors and destroy tumour cells. Yet, cancer cells can evade detection through various mechanisms. Fortunately, research has demonstrated that our immune cells can be enhanced and redirected to target cancerous cells. Although therapies utilizing laboratory-enhanced T cells have shown promising results in treating blood cancers, their use is restricted to the patient's own T cells due to the risk of T cells from unmatched donors attacking the patient's healthy cells. However, a specific type of immune cell called invariant natural killer T (iNKT) cells eliminates this risk. iNKT cells respond to specific signals without triggering harmful reactions when transferred between unrelated individuals, making them an exciting candidate for cancer treatment. They respond by releasing molecules that can directly or indirectly kill tumour cells. iNKT cells possess weapons, such as cytotoxic molecules, which directly kill cancer cells. They also mediate indirect killing by releasing signalling molecules, called cytokines, which activate and recruit other immune cells to join the fight. Moreover, iNKT cells have various subsets with varying functions, some excelling at direct or indirect killing. We have recently identified a subset of iNKT cells with superior anti-tumour function. Therefore, my research aims to explore and enhance cytotoxic iNKT cells for cancer treatment. My findings will contribute valuable insights, propelling advancements in utilizing iNKT cells for more effective cancer therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
505833
Name
Alkassab Daniah
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Unleashing the Power Within: Enhancing Cancer Treatment with Cytotoxic Invariant Natural Killer T Cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Adoptive Cell Therapy/Immunotherapy; Immunology; Invariant Natural Killer T Cells
Abstract
Cancer is a disease that arises when cells divide uncontrollably. Typically, our cells adhere to a pattern of growth, division, and death. However, in cancer, errors occur, leading to persistent cell division and tumour formation. Typically, our immune system can recognize these errors and destroy tumour cells. Yet, cancer cells can evade detection through various mechanisms. Fortunately, research has demonstrated that our immune cells can be enhanced and redirected to target cancerous cells. Although therapies utilizing laboratory-enhanced T cells have shown promising results in treating blood cancers, their use is restricted to the patient's own T cells due to the risk of T cells from unmatched donors attacking the patient's healthy cells. However, a specific type of immune cell called invariant natural killer T (iNKT) cells eliminates this risk. iNKT cells respond to specific signals without triggering harmful reactions when transferred between unrelated individuals, making them an exciting candidate for cancer treatment. They respond by releasing molecules that can directly or indirectly kill tumour cells. iNKT cells possess weapons, such as cytotoxic molecules, which directly kill cancer cells. They also mediate indirect killing by releasing signalling molecules, called cytokines, which activate and recruit other immune cells to join the fight. Moreover, iNKT cells have various subsets with varying functions, some excelling at direct or indirect killing. We have recently identified a subset of iNKT cells with superior anti-tumour function. Therefore, my research aims to explore and enhance cytotoxic iNKT cells for cancer treatment. My findings will contribute valuable insights, propelling advancements in utilizing iNKT cells for more effective cancer therapies.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alkassab, Daniah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~